Pharmaceutical Industry

Competing bipartisan insulin bills affecting Schumer-Sanders healthcare deal

Emily Jacobs · June 17, 2023 8:00 am

Fairness & Justice

Bipartisan Senate group cracks down on pharmacy middlemen to lower drug prices

Gabrielle M. Etzel · June 14, 2023 2:00 pm

Beltway Confidential

An Rx for the persistent problem of prescription drug shortages

Edmund F. Haislmaier · June 14, 2023 1:00 pm

Drug to treat marijuana addiction finds success in clinical trial

Breccan F. Thies · June 9, 2023 8:00 am

Merck sues over drug price negotiations in Democratic Inflation Reduction Act

Gabrielle M. Etzel · June 6, 2023 6:00 pm

Congressional GOP treads on treacherous ground with prescription drug price reform

Beltway Confidential

Congressional GOP treads on treacherous ground with prescription drug price reform

Joe Grogan · June 1, 2023 6:00 am

Bipartisan support on key panel for crackdown on pharmaceutical middlemen

Gabrielle M. Etzel · May 23, 2023 6:43 pm

Ex-FDA commissioner pins drug shortage on Inflation Reduction Act

Jenny Goldsberry · May 22, 2023 12:40 am

Pharma CEOs play insulin price blame game during bipartisan Senate grilling

Emily Jacobs · May 10, 2023 11:04 pm

COVID-era telehealth rule extended to November

Jack Birle · May 9, 2023 5:20 pm

Telemedicine companies celebrate DEA delay of online prescription restrictions

Breccan F. Thies · May 5, 2023 3:27 pm

Packages of Mifepristone tablets are displayed at a family planning clinic on April 13, 2023, in Rockville, Maryland. A Massachusetts appeals court temporarily blocked a Texas-based federal judgeâs ruling that suspended the FDAâs approval of the abortion drug Mifepristone, which is part of a two-drug regimen to induce an abortion in the first trimester of pregnancy in combination with the drug Misoprostol.

Why Big Pharma sees the abortion drug legal fight as a grave business risk

Kaelan Deese · May 4, 2023 11:00 am